GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Walvax Biotechnology Co Ltd (SZSE:300142) » Definitions » Shiller PE Ratio

Walvax Biotechnology Co (SZSE:300142) Shiller PE Ratio : 88.94 (As of May. 08, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Walvax Biotechnology Co Shiller PE Ratio?

As of today (2024-05-08), Walvax Biotechnology Co's current share price is ¥15.12. Walvax Biotechnology Co's E10 for the quarter that ended in Mar. 2024 was ¥0.17. Walvax Biotechnology Co's Shiller PE Ratio for today is 88.94.

The historical rank and industry rank for Walvax Biotechnology Co's Shiller PE Ratio or its related term are showing as below:

SZSE:300142' s Shiller PE Ratio Range Over the Past 10 Years
Min: 82.29   Med: 400   Max: 1351
Current: 88.94

During the past years, Walvax Biotechnology Co's highest Shiller PE Ratio was 1351.00. The lowest was 82.29. And the median was 400.00.

SZSE:300142's Shiller PE Ratio is ranked worse than
90.58% of 531 companies
in the Drug Manufacturers industry
Industry Median: 25.44 vs SZSE:300142: 88.94

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Walvax Biotechnology Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.009. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.17 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Walvax Biotechnology Co Shiller PE Ratio Historical Data

The historical data trend for Walvax Biotechnology Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Walvax Biotechnology Co Shiller PE Ratio Chart

Walvax Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 532.26 365.50 491.23 283.38 143.92

Walvax Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 229.36 162.22 135.62 143.92 91.25

Competitive Comparison of Walvax Biotechnology Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Walvax Biotechnology Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Walvax Biotechnology Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Walvax Biotechnology Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Walvax Biotechnology Co's Shiller PE Ratio falls into.



Walvax Biotechnology Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Walvax Biotechnology Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=15.12/0.17
=88.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Walvax Biotechnology Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Walvax Biotechnology Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.009/114.6694*114.6694
=0.009

Current CPI (Mar. 2024) = 114.6694.

Walvax Biotechnology Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.007 98.200 -0.008
201409 -0.020 98.900 -0.023
201412 0.209 99.000 0.242
201503 -0.030 99.900 -0.034
201506 -0.020 99.500 -0.023
201509 -0.030 100.500 -0.034
201512 -0.520 100.600 -0.593
201603 -0.030 102.200 -0.034
201606 -0.090 101.400 -0.102
201609 -0.050 102.400 -0.056
201612 0.220 102.600 0.246
201703 -0.020 103.200 -0.022
201706 -0.010 103.100 -0.011
201709 0.002 104.100 0.002
201712 -0.324 104.500 -0.356
201803 0.016 105.300 0.017
201806 0.032 104.900 0.035
201809 0.012 106.600 0.013
201812 0.621 106.500 0.669
201903 0.025 107.700 0.027
201906 0.030 107.700 0.032
201909 0.023 109.800 0.024
201912 0.014 111.200 0.014
202003 -0.012 112.300 -0.012
202006 0.051 110.400 0.053
202009 0.241 111.700 0.247
202012 0.363 111.500 0.373
202103 0.021 112.662 0.021
202106 0.181 111.769 0.186
202109 0.029 112.215 0.030
202112 0.039 113.108 0.040
202203 0.024 114.335 0.024
202206 0.238 114.558 0.238
202209 0.075 115.339 0.075
202212 0.117 115.116 0.117
202303 0.107 115.116 0.107
202306 0.177 114.558 0.177
202309 0.061 115.339 0.061
202312 -0.084 114.669 -0.084
202403 0.009 114.669 0.009

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Walvax Biotechnology Co  (SZSE:300142) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Walvax Biotechnology Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Walvax Biotechnology Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Walvax Biotechnology Co (SZSE:300142) Business Description

Traded in Other Exchanges
N/A
Address
Keyuan Road No. 99, 19th Floor, Building 9A, Dingyi Tiancheng Residential Quarter, High & New Tech Development Zone, Yunnan Province, Kunming, CHN, 650106
Walvax Biotechnology Co Ltd biological pharmaceutical enterprise engaged in research and development, production and sales of bio-medicine products. It offers bio-medicines, such as vaccines, blood products, and others. The company's products include Haemophilus influenza type b conjugate vaccines, freeze-dried group A, C meningococcal polysaccharide conjugate vaccines, group ACYW135 meningococcal polysaccharide vaccines, and group A and C meningococcal polysaccharide vaccines.

Walvax Biotechnology Co (SZSE:300142) Headlines

No Headlines